New Student Offer - Use Code HELLO

Register Now

Covovax is approved by DCGI for children aged 7 to 12 years

Published on June 29, 2022
Current Context: The Serum Institute Of India's (SII) Covid-19 vaccine Covovax has been approved by the Drugs Controller General of India (DCGI) for children between the ages group of 7 and 12 years.
Covovax is approved by DCGI for children aged 7 to 12 years
  • As per the recommendation of the expert committee on Covid-19 of the CSDCO DCGI's given approval for emergency use in children.
  • The SEC discussed the EUA application of SII and recommended granting emergency use authorization for Covovax for children aged 7 to 11 years.
  • With this approval, it is almost the last mile covered in the mission of the COVID-19 vaccine for all.
  • Earlier in December 2021, the government had cleared Covovax for restricted use in an emergency in adults and the 12 to 17 years age group.
  • India began inoculating children aged 12-14 years in the past two months.
  • Apart from that, they have also begun administering precautionary doses of vaccines to healthcare and frontline workers and those aged 60 and above.

Question:

Q.1 DGCI has approved which of the following Vaccine for children between the age group of 7 and 12 years?
a. Corbevax
b. Covovax
c. Covaxin
d. Sinopharm
ebook store

About us

ramandeep singh

Ramandeep Singh, your guide to banking and insurance exams. With 14 years of experience and 5000+ selections, Ramandeep understands the path to success, having transitioned himself from Dena Bank and SBI. He's passionate about helping you achieve your banking and insurance dreams.

  • Follow me:
Close Menu
Close Menu